Top 10 Books about Stock Investing to read in 2018. Read more.

BSPM - Biostar Pharmaceuticals

Industry: Drug Manufacturers - Major Sector: Healthcare Exchange: NASDAQ

BSPM - Biostar Pharmaceuticals

Industry: Drug Manufacturers - Major Sector: Healthcare Exchange: NASDAQ

Fri 23'rd Feb 2018

PERIOD 2017-11-24 - 2018-02-23
CHANGE 0.90%
PRICE $3.38






Biostar Pharmaceuticals Stock Analysis

Technical stock analysis for Fri 23'rd Feb 2018

Shorts 0.07% ( 2018-01-31 )
Cash n/a
Loans n/a
Beta 2.10
ROA 2.23
Buy candidate since 2018-01-03 Gain 77.95%

Biostar Pharmaceuticals gained 0.90% in the last trading day, rising from $3.35 to $3.38 The price has fallen in 6 of the last 10 days and is down by -20.84% for this period. Volume fell in the last day by -69 389 shares, and in total, 163 937 shares bought and sold for approximately $554 107. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Access today's Top 5 Buy Candidates


Biostar Pharmaceuticals lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $3.19 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 106.6% during the next 3 months and, with 90% probability hold a price between $6.60 and $10.11 at the end of this period.

Click here for today's Top 5 Trending Companies


Biostar Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $3.73. On a fall, the stock will find some support from the long-term average at approximately $3.02. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Thursday February 22, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

A buy signal from a double bottom formation was found on Thursday February 22, 2018 and based on theory for this formation the price should go up by 2.13% to $5.49 within 11 trading days since signal was issued (Friday March 09, 2018).

Relative Strength Index (RSI)

RSI14 is 41 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Biostar Pharmaceuticals finds support from accumulated volume at $3.36. On the upside the stock meets some resistance from accumulated volume at $3.58, $3.60 and $4.02.

Support: $3.36 Price: $3.38 Resistance: $3.58


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.36 between high and low, or 11.61%. For the last week the stock has had a daily average volatility of 11.01%.

Our recommended stoploss: $3.13 (-7.44%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Trade BSPM CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).